Ulceration and stage are predictive of interferon efficacy in melanoma: Results of the phase III adjuvant trials EORTC 18952 and EORTC 18991
Authors:
- Alexander M.M. EggermontAEAlexander M.M. Eggermont
- Stefan SuciuSSStefan Suciu
- Alessandro TestoriATAlessandro Testori
- Wim H. KruitWKWim H. Kruit
- Jeremy MarsdenJMJeremy Marsden
- Cornelis J. PuntCPCornelis J. Punt
- Mario SantinamiMSMario Santinami
- François SalèsFSFrançois Salès
- Dirk SchadendorfDSDirk Schadendorf
- Poulam PatelPPPoulam Patel
- Reinhard DummerRDReinhard Dummer
- Caroline RobertCRCaroline Robert
- 1 January 2012
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 48 (2) , 218-225
Abstract
No abstract availableKeywords
Funding Information
- Fonds Cancer (FOCA)
This publication has 20 references indexed in Scilit:
- Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV MelanomaClinical Cancer Research, 2011
- Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trialThe Lancet Oncology, 2011
- Anti–CTLA-4 Antibody Adjuvant Therapy in MelanomaSeminars in Oncology, 2010
- Ulceration as a Predictive Marker for Response to Adjuvant Interferon Therapy in MelanomaAnnals of Surgery, 2010
- Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus MacrometastasesJournal of Clinical Oncology, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- Autoimmune Antibodies and Recurrence-Free Interval in Melanoma Patients Treated With Adjuvant InterferonJNCI: Journal of the National Cancer Institute, 2009
- Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic MelanomaClinical Cancer Research, 2007
- Multiplex Analysis of Serum Cytokines in Melanoma Patients Treated with Interferon-α2bClinical Cancer Research, 2007
- Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical OutcomeJNCI: Journal of the National Cancer Institute, 2006